Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 15Triple Negative Breast Neoplasms 9Neoplasms 8Prostatic Neoplasms 6Ovarian Neoplasms 4Neoplasm Metastasis 4Leukemia, Myeloid, Acute 4Fallopian Tube Neoplasms 4Endometrial Neoplasms 4Small Cell Lung Carcinoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Wilms Tumor 1Vaginal Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Metastatic Breast Cancer 1Thrombocythemia, Essential 1Sarcoma, Ewing 1Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Recurrence 1Prostate Cancer Metastatic 1Primary Myelofibrosis 1Premenopausal HR+/HER2- Metastatic Breast Cancer 1Polycythemia Vera 1Pathologic Complete Response 1Osteosarcoma 1Neuroendocrine Tumors 1

Interventions

Sunitinib 26Everolimus 20Bevacizumab 19aldesleukin 18Sorafenib 16Nivolumab 16Interleukin-2 14pembrolizumab 13Peripheral Blood Stem Cell Transplantation 13fludarabine phosphate 12Radiotherapy 12Interferon-alpha 12Cyclophosphamide 12Radiosurgery 11Filgrastim 11Blood Specimen Collection 11Ipilimumab 10Gemcitabine 10Axitinib 9Surveys and Questionnaires 7Gene Expression Profiling 7Cryosurgery 7temsirolimus 6pazopanib 6Surgical Procedures, Operative 6durvalumab 5cabozantinib 5atezolizumab 5Mycophenolic Acid 5Immunohistochemistry 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Kidney Neoplasms × talazoparib × Clear all
NCT04337970 2025-05-28

Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer

Memorial Sloan Kettering Cancer Center

Phase 1/2 Completed
23 enrolled
Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡